Is the activity of partially agonistic MHC:peptide ligands dependent on the quality of immunological help?

Scandinavian Journal of Immunology

Volumn 64, Issue 6, 2006, Pages 581-587

  Uhlin, M ^a   Masucci, M ^a   Levitsky, V ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Johns Hopkins Singapore   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERED PEPTIDE LIGAND; B7 ANTIGEN; CD28 ANTIGEN; DEATH RECEPTOR; EPITOPE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 15; INTERLEUKIN 2; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SUBSTITUTION; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNITY; CANCER CONTROL; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL INTERACTION; CELL SPECIFICITY; CLONAL ANERGY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; EXPERIMENTAL MODEL; FUNCTIONAL ASSESSMENT; GENETIC STABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IN VITRO STUDY; INFECTION CONTROL; INFLUENZA VIRUS; LYMPHATIC SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRUS GENOME; VIRUS INFECTION; VIRUS MUTATION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; VIRUS DISEASES;

EID: 33750744766     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01850.x     Document Type: Review

References (68)

1. Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell 1994;79:913-22.
2. Kersh GJ, Allen PM. Essential flexibility in the T-cell recognition of antigen. Nature 1996;380:495-8.
3. Uhlin M, Sandalova E, Masucci MG, Levitsky V. Help signals provided by lymphokines modulate the activation and apoptotic programs induced by partially agonistic peptides in specific cytotoxic T lymphocytes. Eur J Immunol 2005;35:2929-39.
4. + CTLs. J Immunol 1999;163:2601-9.
5. Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 1995;267:515-8.
6. + T cells in response to antagonist ligands. J Exp Med 1996;184:149-57.
7. Gil D, Schamel WW, Montoya M, Sanchez-Madrid F, Alarcon B. Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation. Cell 2002;109:901-12.
8. Gil D, Schrum AG, Alarcon B, Palmer E. T cell receptor engagement by peptide-MHC ligands induces a conformational change in the CD3 complex of thymocytes. J Exp Med 2005;201:517-22.
9. + T cell function. J Exp Med 2003;198:99-109.
10. Klenerman P, Meier UC, Phillips RE, McMichael AJ. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur J Immunol 1995;25:1927-31.
11. Krogsgaard M, Prado N, Adams EJ et al. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol Cell 2003;12:1367-78.
12. Chen YZ, Lai ZF, Nishi K, Nishimura Y. Modulation of calcium responses by altered peptide ligands in a human T cell clone. Eur J Immunol 1998;28:3929-39.
13. Wulfing C, Sumen C, Sjaastad MD, Wu LC, Dustin ML, Davis MM. Costimulation and endogenous MHC ligands contribute to T cell recognition. Nat Immunol 2002;3:42-7.
14. Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 1995;2:655-63.
15. Ding YH, Baker BM, Garboczi DN, Biddison WE, Wiley DC. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 1999;11:45-56.
16. Jameson SC, Carbone FR, Bevan MJ. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med 1993;177:1541-50.
17. Ely LK, Green KJ, Beddoe T et al. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection. J Immunol 2005;174:5593-601.
18. Wei CH, Uhlin M, Masucci MG, Levitsky V. Tetramer binding and secretion of interferon-gamma in response to antigenic stimulation are compatible with a range of affinities of MHC:TCR interaction and distinct programs of cytotoxic T-lymphocyte activation. Hum Immunol 2002;63:821-33.
19. Kuchroo VK, Greer JM, Kaul D et al. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J Immunol 1994;153:3326-36.
20. De Magistris MT, Alexander J, Coggeshall M et al. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 1992;68:625-34.
21. Meier UC, Klenerman P, Griffin P et al. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science 1995;270:1360-2.
22. Sewell AK, Harcourt GC, Goulder PJ, Price DA, Phillips RE. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides. Eur J Immunol 1997;27:2323-9.
23. Lau LL, Jiang J, Shen H. In vivo modulation of T cell responses and protective immunity by TCR antagonism during infection. J Immunol 2005;174:7970-6.
24. Klenerman P, Rowland-Jones S, McAdam S et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 1994;369:403-7.
25. Francis T Jr. Influenza: the new acquayantance. Ann Intern Med 1953;39:203-21.
26. Klenerman P, Zinkernagel RM. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998;394:482-5.
27. Tester I, Smyk-Pearson S, Wang P et al. Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 2005;201:1725-31.
28. Ogg GS, Jin X, Bonhoeffer S et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998;279:2103-6.
29. Carrabba MG, Castelli C, Maeurer MJ et al. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues. Cancer Res 2003;63:1560-7.
30. Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 2001;358:1749-53.
31. Price DA, Goulder PJ, Klenerman P et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A 1997;94:1890-5.
32. Timm J, Lauer GM, Kavanagh DG et al. CD8 epitope escape and reversion in acute HCV infection. J Exp Med 2004;200:1593-604.
33. + T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J Virol 2005;79:12952-60.
34. Lee JK, Stewart-Jones G, Dong T et al. T cell cross-reactivity and conformational changes during TCR engagement. J Exp Med 2004;200:1455-66.
35. Grakoui A, Shoukry NH, Woollard DJ et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003;302:659-62.
36. Borrow P, Lewicki H, Wei X et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205-11.
37. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990;248:1349-56.
38. Jenkins MK, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci U S A 1987;84:5409-13.
39. Hollsberg P, Batra V, Dressel A, Hafler DA. Induction of anergy in CD8 T cells by B cell presentation of antigen. J Immunol 1996;157:5269-76.
40. + T cells become nonresponsive (anergic) following activation in the presence of costimulation. J Immunol 1999;163:102-10.
41. Tham EL, Shrikant P, Mescher MF. Activation-induced nonresponsiveness: a Th-dependent regulatory checkpoint in the CTL response. J Immunol 2002;168:1190-7.
42. Heissmeyer V, Macian F, Im SH et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol 2004;5:255-65.
43. Tham EL, Mescher MF. Signaling alterations in activation-induced nonresponsive CD8 T cells. J Immunol 2001;167:2040-8.
44. Lee KH, Holdorf AD, Dustin ML, Chan AC, Allen PM, Shaw AS. T cell receptor signaling precedes immunological synapse formation. Science 2002;295:1539-42.
45. Valitutti S, Lanzavecchia A. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today 1997;18:299-304.
46. Penna D, Muller S, Martinon F, Demotz S, Iwashima M, Valitutti S. Degradation of ZAP-70 following antigenic stimulation in human T lymphocytes: role of calpain proteolytic pathway. J Immunol 1999;163:50-6.
47. + cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 2005;102:9264-9.
48. Desbarats J, You-Ten KE, Lapp WS. Levels of p56lck and p59fyn are reduced by a glucocorticoid-dependent mechanism in graft-versus-host reaction-induced T cell anergy. Cell Immunol 1995;163:10-8.
49. Maccalli C, Pisarra P, Vegetti C, Sensi M, Parmiani G, Anichini A. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions. J Immunol 1999;163:6912-23.
50. Matache C, Onu A, Stefanescu M et al. Dysregulation of p56lck kinase in patients with systemic lupus erythematosus. Autoimmunity 2001;34:27-38.
51. Kanai T, Thomas EK, Yasutomi Y, Letvin NL. IL-15 stimulates the expansion of AIDS virus-specific CTL. J Immunol 1996;157:3681-7.
52. + cell noncytotoxic anti-HIV responses: the role of IL-15. Blood 2004;103:2699-704.
53. Oh S, Berzofsky JA, Burke DS, Waldmann TA, Perera LP. Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc Natl Acad Sci U S A 2003;100:3392-7.
54. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 2005;23:307-36.
55. Renno T, Hahne M, Tschopp J, MacDonald HR. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med 1996;183:431-7.
56. Mogil RJ, Radvanyi L, Gonzalez-Quintial R et al. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int Immunol 1995;7:1451-8.
57. Hildeman DA, Zhu Y, Mitchell TC et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 2002;16:759-67.
58. Bouillet P, Purton JF, Godfrey DI et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002;415:922-6.
59. Bouillet P, Metcalf D, Huang DC et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999;286:1735-8.
60. Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 2003;198:1119-26.
61. O'Connor L, Strasser A, O'Reilly LA et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. Embo J 1998;17:384-95.
62. Putcha GV, Harris CA, Moulder KL, Easton RM, Thompson CB, Johnson EM Jr. Intrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from the analysis of mutant mice. J Cell Biol 2002;157:441-53.
63. Deverman BE, Cook BL, Manson SR et al. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 2002;111:51-62.
64. Sandalova E, Wei CH, Masucci MG, Levitsky V. Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering. Proc Natl Acad Sci U S A 2004;101:3011-6.
65. + T cell frequencies. J Infect Dis 2004;190:713-21.
66. + cytotoxic T lymphocyte response. J Exp Med 2004;200:1243-56.
67. McMichael AJ, Phillips RE. Escape of human immunodeficiency virus from immune control. Annu Rev Immunol 1997;15:271-96.
68. Collins KL. How HIV evades CTL recognition. Curr HIV Res 2003;1:31-40.